$DSNG had Director 10% - George Simeon buy 900,000 shares on Dec. 20, 2022 and Rodney Lappe, DIR bought 112,024 shares on December 9, 2022. This tells me they are bullish about their company. I also see the MACD sellers cooling and some nice volume coming in. Many are at the $8.06 level and the $16 level. I will wait for the MACD to cross for an entry. But the...
IPO intraday trading strategy idea
Design Therapeutics is a biotechnology company developing a platform of gene targeted chimera (GeneTAC™) small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still...